Login / Signup

Favorable response to carbamazepine therapy in genetically proven myoclonus-dystonia child.

Mohammed F AljabriNaglaa M KamalAbdulrhman AlghamdiHamdan AlghamdiNaif Alomairi
Published in: Italian journal of pediatrics (2021)
Our patient and the other previously reported cases might highlight the response of SGCE mutations to carbamazepine therapy.
Keyphrases
  • mental health
  • early onset
  • deep brain stimulation
  • mesenchymal stem cells
  • cell therapy
  • replacement therapy
  • smoking cessation